Boston Scientific has issued an FDA earning letter recommending certain stents and electrocautery enhanced delivery systems be removed from where they are used or sold. Affected products include 1,660 ...
The FDA sent an early safety alert warning clinicians of deployment failures with certain Boston Scientific AXIOS Stent and Electrocautery Enhanced Delivery Systems that have been linked to three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results